John T. Curnutte, Executive Vice President at PORTOLA PHARMACEUTICALS INC (PTLA), sold 30,000 shares at $28.00 ($850K) on 2014-06-17, disclosed to the SEC on 2014-06-19.
Scheduled sale ($850k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 10,000 | $270K | 31.8% |
| 2 | $28.00 | 10,000 | $280K | 32.9% |
| 3 | $30.00 | 10,000 | $300K | 35.3% |
| Total | $28.33 avg | 30,000 | $850K | 100% |
| Filing → |
| PTLA | SELL | 2015-07-15 | $500K | — | Filing → |
| PTLA | SELL | 2015-06-22 | $475K | — | Filing → |
| PTLA | SELL | 2015-06-17 | $450K | — | Filing → |